Global Plasma Fractionation Market Overview:
Global Plasma Fractionation Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Plasma Fractionation Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Plasma Fractionation involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Plasma Fractionation Market:
The Plasma Fractionation Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Plasma Fractionation Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Plasma Fractionation Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Plasma Fractionation market has been segmented into:
Immunoglobulins
Albumin
Coagulation Factor Concentrates
Protease Inhibitors
Other Products
By Application, Plasma Fractionation market has been segmented into:
Neurology
Immunology
Hematology
Oncology
Pulmonology
Other Applications
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Plasma Fractionation market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Plasma Fractionation market.
Top Key Players Covered in Plasma Fractionation market are:
Bio Products Laboratory Ltd.
Biotest AG
China Biologic Products Inc.
CSL Limited
Green Cross Corporation
Grifols SA
Japan Blood Products Organization
Kedrion SpA
LFB SA
Octapharma AG
Sanquin
Shanghai RAAS Blood Products Co. Ltd.
Shire PLC
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Plasma Fractionation Market Type
4.1 Plasma Fractionation Market Snapshot and Growth Engine
4.2 Plasma Fractionation Market Overview
4.3 Immunoglobulins
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Immunoglobulins: Geographic Segmentation Analysis
4.4 Albumin
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Albumin: Geographic Segmentation Analysis
4.5 Coagulation Factor Concentrates
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Coagulation Factor Concentrates: Geographic Segmentation Analysis
4.6 Protease Inhibitors
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Protease Inhibitors: Geographic Segmentation Analysis
4.7 Other Products
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Other Products: Geographic Segmentation Analysis
Chapter 5: Plasma Fractionation Market Application
5.1 Plasma Fractionation Market Snapshot and Growth Engine
5.2 Plasma Fractionation Market Overview
5.3 Neurology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Neurology: Geographic Segmentation Analysis
5.4 Immunology
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Immunology: Geographic Segmentation Analysis
5.5 Hematology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Hematology: Geographic Segmentation Analysis
5.6 Oncology
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Oncology: Geographic Segmentation Analysis
5.7 Pulmonology
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Pulmonology: Geographic Segmentation Analysis
5.8 Other Applications
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Other Applications: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Plasma Fractionation Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BIO PRODUCTS LABORATORY LTD.; BIOTEST AG; CHINA BIOLOGIC PRODUCTS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; CSL LIMITED; GREEN CROSS CORPORATION; GRIFOLS SA; JAPAN BLOOD PRODUCTS ORGANIZATION; KEDRION SPA; LFB SA; OCTAPHARMA AG; SANQUIN; SHANGHAI RAAS BLOOD PRODUCTS CO.
6.4 LTD.; SHIRE PLC
Chapter 7: Global Plasma Fractionation Market By Region
7.1 Overview
7.2. North America Plasma Fractionation Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Immunoglobulins
7.2.2.2 Albumin
7.2.2.3 Coagulation Factor Concentrates
7.2.2.4 Protease Inhibitors
7.2.2.5 Other Products
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Neurology
7.2.3.2 Immunology
7.2.3.3 Hematology
7.2.3.4 Oncology
7.2.3.5 Pulmonology
7.2.3.6 Other Applications
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Plasma Fractionation Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Immunoglobulins
7.3.2.2 Albumin
7.3.2.3 Coagulation Factor Concentrates
7.3.2.4 Protease Inhibitors
7.3.2.5 Other Products
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Neurology
7.3.3.2 Immunology
7.3.3.3 Hematology
7.3.3.4 Oncology
7.3.3.5 Pulmonology
7.3.3.6 Other Applications
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Plasma Fractionation Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Immunoglobulins
7.4.2.2 Albumin
7.4.2.3 Coagulation Factor Concentrates
7.4.2.4 Protease Inhibitors
7.4.2.5 Other Products
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Neurology
7.4.3.2 Immunology
7.4.3.3 Hematology
7.4.3.4 Oncology
7.4.3.5 Pulmonology
7.4.3.6 Other Applications
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Plasma Fractionation Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Immunoglobulins
7.5.2.2 Albumin
7.5.2.3 Coagulation Factor Concentrates
7.5.2.4 Protease Inhibitors
7.5.2.5 Other Products
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Neurology
7.5.3.2 Immunology
7.5.3.3 Hematology
7.5.3.4 Oncology
7.5.3.5 Pulmonology
7.5.3.6 Other Applications
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Plasma Fractionation Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Immunoglobulins
7.6.2.2 Albumin
7.6.2.3 Coagulation Factor Concentrates
7.6.2.4 Protease Inhibitors
7.6.2.5 Other Products
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Neurology
7.6.3.2 Immunology
7.6.3.3 Hematology
7.6.3.4 Oncology
7.6.3.5 Pulmonology
7.6.3.6 Other Applications
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Plasma Fractionation Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Immunoglobulins
7.7.2.2 Albumin
7.7.2.3 Coagulation Factor Concentrates
7.7.2.4 Protease Inhibitors
7.7.2.5 Other Products
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Neurology
7.7.3.2 Immunology
7.7.3.3 Hematology
7.7.3.4 Oncology
7.7.3.5 Pulmonology
7.7.3.6 Other Applications
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Plasma Fractionation Scope:
|
Report Data
|
Plasma Fractionation Market
|
|
Plasma Fractionation Market Size in 2025
|
USD XX million
|
|
Plasma Fractionation CAGR 2025 - 2032
|
XX%
|
|
Plasma Fractionation Base Year
|
2024
|
|
Plasma Fractionation Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Inc., CSL Limited, Green Cross Corporation, Grifols SA, Japan Blood Products Organization, Kedrion SpA, LFB SA, Octapharma AG, Sanquin, Shanghai RAAS Blood Products Co. Ltd., Shire PLC.
|
|
Key Segments
|
By Type
Immunoglobulins
Albumin
Coagulation Factor Concentrates
Protease Inhibitors
Other Products
By Applications
Neurology
Immunology
Hematology
Oncology
Pulmonology
Other Applications
|
